Michael Baim serves as Executive at BIOANALYTICAL SYSTEMS INC, where they oversee executive responsibilities. Since joining the company, Michael Baim has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Dec 2, 2020 involved receiving (via award) 6,938 shares valued at $0.
Michael Baim currently holds 14,656 shares of BIOANALYTICAL SYSTEMS INC (BASI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael Baim has been a net neutral trader of BASI stock. They have purchased $0 and sold $0 worth of shares.
Michael Baim's most recent insider trade was on Dec 2, 2020, when they sold 6,938 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Dec 2, 2019 | BASI | $0 | Award | 7,718 | $N/A | Discretionary |